TargetSerine/threonine-protein kinase Chk2(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 61nMAssay Description:Inhibition of recombinant human Chk2 kinaseMore data for this Ligand-Target Pair